Netcall (NET) Competitors

Netcall (LON:NET) and Dr. Martens (LON:DOCS) are both small-cap computer software companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

Does the media favor NET or DOCS?

In the previous week, Dr. Martens had 6 more articles in the media than Netcall. MarketBeat recorded 8 mentions for Dr. Martens and 2 mentions for Netcall. Dr. Martens' average media sentiment score of 1.09 beat Netcall's score of 0.45 indicating that Dr. Martens is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Netcall	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Dr. Martens	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend NET or DOCS?

Netcall presently has a consensus target price of GBX 138.33, suggesting a potential upside of 15.76%. Dr. Martens has a consensus target price of GBX 6,000, suggesting a potential upside of 7,845.97%. Given Dr. Martens' higher probable upside, analysts clearly believe Dr. Martens is more favorable than Netcall.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Netcall	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Dr. Martens	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Do insiders & institutionals believe in NET or DOCS?

69.3% of Netcall shares are held by institutional investors. Comparatively, 69.5% of Dr. Martens shares are held by institutional investors. 11.5% of Netcall shares are held by insiders. Comparatively, 4.4% of Dr. Martens shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Is NET or DOCS a better dividend stock?

Netcall pays an annual dividend of GBX 1 per share and has a dividend yield of 0.8%. Dr. Martens pays an annual dividend of GBX 3 per share and has a dividend yield of 4.0%. Netcall pays out 28.2% of its earnings in the form of a dividend. Dr. Martens pays out 42.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Which has better valuation and earnings, NET or DOCS?

Dr. Martens has higher revenue and earnings than Netcall. Dr. Martens is trading at a lower price-to-earnings ratio than Netcall, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Netcall	£39.16M	5.04	£5.87M	£3.55	33.65
Dr. Martens	£874.20M	0.84	£68.97M	£7.05	10.70

Is NET or DOCS more profitable?

Netcall has a net margin of 14.99% compared to Dr. Martens' net margin of 7.89%. Dr. Martens' return on equity of 18.91% beat Netcall's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Netcall	14.99%	14.95%	4.62%
Dr. Martens	7.89%	18.91%	8.12%

Which has more volatility & risk, NET or DOCS?

Netcall has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500. Comparatively, Dr. Martens has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500.

Summary

Dr. Martens beats Netcall on 10 of the 18 factors compared between the two stocks.